South Korea Pharmaceutical Logistics Market

South Korea pharmaceutical logistics market, valued at USD 2.2 billion, is growing due to rising biopharma demand, cold chain investments, and e-commerce, with key hubs in Seoul, Busan, and Incheon.

Region:Asia

Author(s):Shubham

Product Code:KRAA0903

Pages:88

Published On:August 2025

About the Report

Base Year 2024

South Korea Pharmaceutical Logistics Market Overview

  • The South Korea Pharmaceutical Logistics Market is valued at USD 2.2 billion, based on a five-year historical analysis. This growth is primarily driven by the increasing demand for efficient and reliable logistics solutions in the pharmaceutical sector, particularly due to the rise in biopharmaceutical products and the need for temperature-sensitive transportation. The market has seen significant investments in cold chain infrastructure and digital tracking technologies to ensure compliance and product integrity .
  • Key cities such as Seoul, Busan, and Incheon dominate the market due to their strategic locations, advanced infrastructure, and proximity to major healthcare facilities and research institutions. These cities serve as critical hubs for pharmaceutical distribution, facilitating faster delivery and improved access to healthcare services .
  • South Korea has implemented stricter regulations on pharmaceutical logistics, mandating compliance with Good Distribution Practices (GDP) for all providers. These regulatory measures are designed to enhance the safety and efficacy of drug distribution, ensuring that all pharmaceutical products are stored and transported under optimal conditions. While there is no official "Pharmaceutical Logistics Improvement Act" enacted in 2023, the government has strengthened GDP enforcement and oversight in recent years .
South Korea Pharmaceutical Logistics Market Size

South Korea Pharmaceutical Logistics Market Segmentation

By Type:The market is segmented into various types of logistics services, including Cold Chain Logistics, Non-Cold Chain Logistics, Last-Mile Delivery Services, Freight Forwarding Services, Warehousing Solutions, and Value-Added Services. Cold chain logistics are increasingly critical due to the growing share of temperature-sensitive biopharmaceuticals and vaccines, while non-cold chain logistics continue to serve the bulk of conventional pharmaceuticals. Last-mile delivery and value-added services such as labeling, kitting, and returns management are gaining importance with the rise of e-commerce and direct-to-patient distribution models .

South Korea Pharmaceutical Logistics Market segmentation by Type.

By End-User:The end-user segmentation includes Biopharmaceutical Companies, Hospitals & Clinics, Pharmacies & Drug Stores, Research & Academic Institutions, and Wholesalers & Distributors. Biopharmaceutical companies and hospitals are the largest end-users, driven by high-value, temperature-sensitive products and the need for stringent compliance. Pharmacies, research institutions, and wholesalers also contribute significantly, each with distinct logistics requirements .

South Korea Pharmaceutical Logistics Market segmentation by End-User.

South Korea Pharmaceutical Logistics Market Competitive Landscape

The South Korea Pharmaceutical Logistics Market is characterized by a dynamic mix of regional and international players. Leading participants such as CJ Logistics, Hanjin Transportation, Logen, Lotte Global Logistics, DB Schenker Korea, DHL Supply Chain Korea, Kuehne + Nagel Korea, Samsung SDS, SK Networks, Pantos Logistics (LG CNS), Yusen Logistics Korea, Nippon Express Korea, SF Express Korea, FedEx Korea, UPS Korea contribute to innovation, geographic expansion, and service delivery in this space.

CJ Logistics

1930

Seoul, South Korea

Hanjin Transportation

1945

Seoul, South Korea

Logen

2004

Seoul, South Korea

Lotte Global Logistics

2013

Seoul, South Korea

DB Schenker Korea

2003

Seoul, South Korea

Company

Establishment Year

Headquarters

Company Size (by revenue or employee count)

Annual Revenue from Pharmaceutical Logistics

Revenue Growth Rate (CAGR)

Market Share in Pharmaceutical Logistics

Customer Retention Rate

On-Time Delivery Rate

South Korea Pharmaceutical Logistics Market Industry Analysis

Growth Drivers

  • Increasing Demand for Temperature-Controlled Logistics:The South Korean pharmaceutical logistics sector is witnessing a surge in demand for temperature-controlled logistics, driven by the biopharmaceutical industry's growth. In future, the biopharmaceutical market in South Korea was valued at approximately $10 billion, with a projected increase to $12 billion. This growth necessitates advanced cold chain logistics to ensure product integrity, particularly for temperature-sensitive medications, which are expected to account for over 30% of total pharmaceutical shipments.
  • Expansion of Biopharmaceuticals:The biopharmaceutical sector is expanding rapidly, with South Korea's government investing around $1.5 billion in biopharmaceutical research and development. This investment is expected to yield a 15% increase in biopharmaceutical production. As a result, the demand for specialized logistics services that can handle complex biopharmaceutical products, including biologics and biosimilars, is anticipated to rise significantly, driving the need for enhanced logistics capabilities.
  • Rising E-commerce in Pharmaceuticals:The e-commerce segment of the pharmaceutical industry in South Korea is projected to reach $3 billion, reflecting a 20% increase. This growth is fueled by changing consumer behaviors and the increasing preference for online purchasing of medications. Consequently, logistics providers are adapting their services to accommodate the unique requirements of e-commerce, including faster delivery times and improved tracking systems, which are essential for maintaining customer satisfaction and compliance.

Market Challenges

  • Stringent Regulatory Compliance:The South Korean pharmaceutical logistics market faces significant challenges due to stringent regulatory compliance requirements. In future, the Ministry of Food and Drug Safety (MFDS) implemented over 50 new regulations aimed at enhancing drug safety and distribution standards. Compliance with these regulations often requires substantial investments in training and technology, which can strain the operational budgets of logistics providers, particularly smaller firms that may lack the necessary resources.
  • High Operational Costs:Operational costs in the South Korean pharmaceutical logistics sector are rising, with average logistics costs estimated at $1.2 billion. Factors contributing to these costs include rising fuel prices, labor shortages, and the need for advanced technology to ensure compliance and efficiency. As logistics providers strive to maintain profitability while meeting increasing service demands, these high operational costs pose a significant challenge to sustainable growth in the sector.

South Korea Pharmaceutical Logistics Market Future Outlook

The South Korean pharmaceutical logistics market is poised for significant transformation, driven by technological advancements and evolving consumer expectations. The integration of IoT and AI technologies is expected to enhance supply chain efficiency, enabling real-time tracking and predictive analytics. Additionally, the focus on sustainability will likely lead to the adoption of eco-friendly logistics practices. As the market adapts to these trends, stakeholders must remain agile to capitalize on emerging opportunities while navigating regulatory complexities and operational challenges.

Market Opportunities

  • Growth in Home Healthcare Services:The increasing demand for home healthcare services presents a significant opportunity for pharmaceutical logistics providers. With an estimated 1.5 million patients receiving home healthcare, logistics companies can expand their services to include home delivery of medications, enhancing patient access and convenience while ensuring compliance with safety standards.
  • Technological Advancements in Logistics:The rapid advancement of logistics technology, including automation and AI, offers substantial opportunities for efficiency improvements. By investing in these technologies, logistics providers can streamline operations, reduce costs, and enhance service delivery, positioning themselves competitively in a market that increasingly values speed and reliability.

Scope of the Report

SegmentSub-Segments
By Type

Cold Chain Logistics

Non-Cold Chain Logistics

Last-Mile Delivery Services

Freight Forwarding Services

Warehousing Solutions

Value-Added Services (e.g., labeling, kitting, returns management)

By End-User

Biopharmaceutical Companies

Hospitals & Clinics

Pharmacies & Drug Stores

Research & Academic Institutions

Wholesalers & Distributors

By Distribution Mode

Direct Distribution

Third-Party Logistics (3PL)

E-commerce & Online Pharmacies

Hybrid Models

By Service Type

Transportation Services (Road, Air, Sea)

Warehousing & Storage

Inventory & Order Management

Packaging & Repackaging

Regulatory Compliance Services

By Temperature Control

Ambient (15–25°C)

Refrigerated (2–8°C)

Frozen (below –20°C)

Ultra-Cold Chain (–70°C and below)

By Compliance Type

Good Distribution Practice (GDP) Compliance

Good Manufacturing Practice (GMP) Compliance

ISO 9001/13485 Certification

Other Regulatory Standards

By Pricing Strategy

Cost-Plus Pricing

Value-Based Pricing

Competitive Pricing

Contract-Based Pricing

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Food and Drug Safety, Korea Pharmaceutical and Bio-Pharma Manufacturers Association)

Pharmaceutical Manufacturers

Logistics and Supply Chain Companies

Cold Chain Service Providers

Healthcare Providers and Hospitals

Pharmacy Chains and Retail Pharmacies

Insurance Companies and Payers

Players Mentioned in the Report:

CJ Logistics

Hanjin Transportation

Logen

Lotte Global Logistics

DB Schenker Korea

DHL Supply Chain Korea

Kuehne + Nagel Korea

Samsung SDS

SK Networks

Pantos Logistics (LG CNS)

Yusen Logistics Korea

Nippon Express Korea

SF Express Korea

FedEx Korea

UPS Korea

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. South Korea Pharmaceutical Logistics Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 South Korea Pharmaceutical Logistics Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. South Korea Pharmaceutical Logistics Market Analysis

3.1 Growth Drivers

3.1.1 Increasing Demand for Temperature-Controlled Logistics
3.1.2 Expansion of Biopharmaceuticals
3.1.3 Rising E-commerce in Pharmaceuticals
3.1.4 Government Initiatives for Healthcare Improvement

3.2 Market Challenges

3.2.1 Stringent Regulatory Compliance
3.2.2 High Operational Costs
3.2.3 Limited Infrastructure in Rural Areas
3.2.4 Competition from Global Players

3.3 Market Opportunities

3.3.1 Growth in Home Healthcare Services
3.3.2 Technological Advancements in Logistics
3.3.3 Increasing Investment in Cold Chain Solutions
3.3.4 Expansion into Emerging Markets

3.4 Market Trends

3.4.1 Adoption of IoT in Logistics
3.4.2 Shift Towards Automation and Robotics
3.4.3 Focus on Sustainability Practices
3.4.4 Integration of AI for Supply Chain Optimization

3.5 Government Regulation

3.5.1 Pharmaceutical Distribution Licensing Requirements
3.5.2 Cold Chain Compliance Standards
3.5.3 Import and Export Regulations for Pharmaceuticals
3.5.4 Data Protection Regulations in Healthcare Logistics

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. South Korea Pharmaceutical Logistics Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. South Korea Pharmaceutical Logistics Market Segmentation

8.1 By Type

8.1.1 Cold Chain Logistics
8.1.2 Non-Cold Chain Logistics
8.1.3 Last-Mile Delivery Services
8.1.4 Freight Forwarding Services
8.1.5 Warehousing Solutions
8.1.6 Value-Added Services (e.g., labeling, kitting, returns management)

8.2 By End-User

8.2.1 Biopharmaceutical Companies
8.2.2 Hospitals & Clinics
8.2.3 Pharmacies & Drug Stores
8.2.4 Research & Academic Institutions
8.2.5 Wholesalers & Distributors

8.3 By Distribution Mode

8.3.1 Direct Distribution
8.3.2 Third-Party Logistics (3PL)
8.3.3 E-commerce & Online Pharmacies
8.3.4 Hybrid Models

8.4 By Service Type

8.4.1 Transportation Services (Road, Air, Sea)
8.4.2 Warehousing & Storage
8.4.3 Inventory & Order Management
8.4.4 Packaging & Repackaging
8.4.5 Regulatory Compliance Services

8.5 By Temperature Control

8.5.1 Ambient (15–25°C)
8.5.2 Refrigerated (2–8°C)
8.5.3 Frozen (below –20°C)
8.5.4 Ultra-Cold Chain (–70°C and below)

8.6 By Compliance Type

8.6.1 Good Distribution Practice (GDP) Compliance
8.6.2 Good Manufacturing Practice (GMP) Compliance
8.6.3 ISO 9001/13485 Certification
8.6.4 Other Regulatory Standards

8.7 By Pricing Strategy

8.7.1 Cost-Plus Pricing
8.7.2 Value-Based Pricing
8.7.3 Competitive Pricing
8.7.4 Contract-Based Pricing

9. South Korea Pharmaceutical Logistics Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Company Size (by revenue or employee count)
9.2.3 Annual Revenue from Pharmaceutical Logistics
9.2.4 Revenue Growth Rate (CAGR)
9.2.5 Market Share in Pharmaceutical Logistics
9.2.6 Customer Retention Rate
9.2.7 On-Time Delivery Rate
9.2.8 Cold Chain Capacity (cubic meters or pallet positions)
9.2.9 Number of Distribution Centers/Warehouses
9.2.10 Technology Adoption Level (e.g., IoT, automation, track & trace)
9.2.11 Regulatory Compliance Record (GDP/GMP/ISO certifications)
9.2.12 Service Portfolio Breadth (range of logistics services offered)
9.2.13 Sustainability Initiatives (green logistics, carbon footprint)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 CJ Logistics
9.5.2 Hanjin Transportation
9.5.3 Logen
9.5.4 Lotte Global Logistics
9.5.5 DB Schenker Korea
9.5.6 DHL Supply Chain Korea
9.5.7 Kuehne + Nagel Korea
9.5.8 Samsung SDS
9.5.9 SK Networks
9.5.10 Pantos Logistics (LG CNS)
9.5.11 Yusen Logistics Korea
9.5.12 Nippon Express Korea
9.5.13 SF Express Korea
9.5.14 FedEx Korea
9.5.15 UPS Korea

10. South Korea Pharmaceutical Logistics Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Ministry of Health and Welfare
10.1.2 Ministry of Food and Drug Safety
10.1.3 Ministry of Trade, Industry and Energy

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Cold Chain Facilities
10.2.2 Budget Allocation for Technology Upgrades
10.2.3 Spending on Compliance and Regulatory Training

10.3 Pain Point Analysis by End-User Category

10.3.1 Delays in Delivery
10.3.2 High Costs of Logistics
10.3.3 Compliance Challenges

10.4 User Readiness for Adoption

10.4.1 Awareness of New Technologies
10.4.2 Training and Skill Development
10.4.3 Financial Readiness

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of Cost Savings
10.5.2 Expansion of Service Offerings
10.5.3 Customer Satisfaction Metrics

11. South Korea Pharmaceutical Logistics Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Identification of Market Gaps

1.2 Value Proposition Development

1.3 Revenue Stream Analysis

1.4 Key Partnerships

1.5 Cost Structure Analysis

1.6 Customer Segmentation

1.7 Channels of Distribution


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs

2.3 Target Audience Identification

2.4 Communication Strategy

2.5 Digital Marketing Approaches


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-Ups

3.3 Logistics Partnerships

3.4 Distribution Channel Optimization


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands Analysis

4.3 Competitor Pricing Strategies

4.4 Customer Willingness to Pay


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments Analysis

5.3 Emerging Trends in Consumer Preferences


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service Enhancements

6.3 Customer Feedback Mechanisms


7. Value Proposition

7.1 Sustainability Initiatives

7.2 Integrated Supply Chains

7.3 Cost Efficiency


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding Initiatives

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix Considerations
9.1.2 Pricing Band Strategy
9.1.3 Packaging Innovations

9.2 Export Entry Strategy

9.2.1 Target Countries Identification
9.2.2 Compliance Roadmap Development

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model Evaluation


11. Capital and Timeline Estimation

11.1 Capital Requirements Analysis

11.2 Timelines for Market Entry


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships

12.2 Risk Mitigation Strategies


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability Strategies


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Identification
15.2.2 Activity Scheduling

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of industry reports from South Korean pharmaceutical associations and logistics bodies
  • Review of government publications on pharmaceutical regulations and logistics frameworks
  • Examination of market trends through academic journals and white papers on pharmaceutical supply chains

Primary Research

  • Interviews with logistics managers at major pharmaceutical companies in South Korea
  • Telephonic surveys with industry experts and consultants specializing in pharmaceutical logistics
  • Field interviews with warehouse and distribution center supervisors in the pharmaceutical sector

Validation & Triangulation

  • Cross-validation of findings using multiple data sources, including trade statistics and sales data
  • Triangulation of insights from primary interviews with secondary research findings
  • Sanity checks through expert panel discussions and feedback sessions

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of total pharmaceutical logistics spending based on national healthcare expenditure
  • Segmentation of the market by pharmaceutical categories and distribution channels
  • Incorporation of trends in e-commerce and telehealth impacting logistics demand

Bottom-up Modeling

  • Volume estimates derived from logistics operations of leading pharmaceutical distributors
  • Cost analysis based on service pricing models for cold chain and standard logistics
  • Calculation of total logistics costs based on volume and frequency of pharmaceutical shipments

Forecasting & Scenario Analysis

  • Multi-factor regression analysis incorporating growth rates of the pharmaceutical market and logistics innovations
  • Scenario modeling based on potential regulatory changes and shifts in consumer behavior
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Pharmaceutical Distribution Logistics60Logistics Managers, Supply Chain Analysts
Cold Chain Management45Operations Managers, Quality Assurance Heads
Regulatory Compliance in Logistics40Compliance Officers, Regulatory Affairs Managers
Last-Mile Delivery Solutions40Delivery Managers, Customer Service Representatives
Pharmaceutical Returns Management45Returns Managers, Inventory Control Specialists

Frequently Asked Questions

What is the current value of the South Korea Pharmaceutical Logistics Market?

The South Korea Pharmaceutical Logistics Market is valued at approximately USD 2.2 billion, reflecting significant growth driven by the increasing demand for efficient logistics solutions, particularly for biopharmaceutical products and temperature-sensitive transportation.

What are the key drivers of growth in the South Korea Pharmaceutical Logistics Market?

Which cities are the main hubs for pharmaceutical logistics in South Korea?

What regulations govern pharmaceutical logistics in South Korea?

Other Regional/Country Reports

Indonesia South Korea Pharmaceutical Logistics Market

Malaysia South Korea Pharmaceutical Logistics Market

KSA South Korea Pharmaceutical Logistics Market

APAC South Korea Pharmaceutical Logistics Market

SEA South Korea Pharmaceutical Logistics Market

Vietnam South Korea Pharmaceutical Logistics Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022